首页|CYP2C19基因多态性、血清NT-proBNP水平与急性脑梗死静脉溶栓预后不良的关系

CYP2C19基因多态性、血清NT-proBNP水平与急性脑梗死静脉溶栓预后不良的关系

扫码查看
目的 探讨CYP2C19基因多态性、血清N末端B型脑利钠肽前体(NT-proBNP)水平与急性脑梗死(ACI)患者静脉溶栓预后不良的关系。方法 选择210例ACI患者,均行阿替普酶静脉溶栓治疗,治疗90 d后根据改良Rankin量表(mRS)评分将患者分为预后不良组(mRS评分≥3分)52例、预后良好组(mRS评分<3分)158例。治疗前采用实时荧光定量PCR法检测CYP2C19基因多态性,时间分辨荧光免疫层析法检测血清NT-proBNP。用Pearson或Spearman分析CYP2C19基因多态性、血清NT-proBNP水平与mRS评分的相关性;用多因素Logistic回归分析ACI患者静脉溶栓预后的影响因素;用受试者工作特征曲线分析CYP2C19基因多态性、血清NT-proBNP水平对ACI患者静脉溶栓预后不良的预测价值。结果 预后不良组年龄、高血压比例、糖尿病比例、入院美国国立卫生研究所脑卒中(NIHSS)评分、空腹血糖水平高于预后良好组(P均<0。05)。预后不良组和预后良好组CYP2C19基因多态性比较差异有统计学意义(P<0。05),预后不良组血清NT-proBNP水平高于预后良好组(P<0。05)。ACI患者CYP2C19基因多态性(rs=0。362)、血清NT-proBNP水平(r=0。426)与mRS评分均呈正相关(P均<0。05)。高NIHSS评分、CYP2C19基因慢代谢型、高血清NT-proBNP水平是ACI患者预后不良的危险因素(P均<0。05)。CYP2C19基因多态性、血清NT-proBNP水平单独及联合预测ACI患者静脉溶栓预后的曲线下面积分别为0。752、0。786、0。861,二者联合预测的曲线下面积高于单独预测(P均<0。05)。结论 CYP2C19基因多态性和高水平NT-proBNP是ACI患者静脉溶栓预后不良的危险因素,二者联合对不良预后有较高的预测价值。
Relationships of CYP2C19 gene polymorphism and serum NT-proBNP level with poor prognosis of intravenous thrombolysis in acute cerebral infarction
Objective To explore the relationships between CYP2C19 gene polymorphism,serum N-terminal B-type brain natriuretic peptide precursor(NT-proBNP)level,and poor prognosis of intravenous thrombolysis in patients with acute cerebral infarction(ACI).Methods A total of 210 patients with ACI were selected and treated with intrave-nous thrombolysis with alteplase.After 90 days of treatment,patients were divided into the poor prognosis group(mRS score≥3 points)of 52 cases and good prognosis group(mRS score<3 points)of 158 cases based on the modified Rankin Scale(mRS)score.Before treatment,real-time fluorescence quantitative PCR was used to detect CYP2C19 gene polymor-phism,and time-resolved fluorescence immunoassay was used to detect serum NT-proBNP.The correlations between CYP2C19 gene polymorphism,serum NT-proBNP level and mRS Score were analyzed by Pearson or Spearman.Multivari-ate Logistic regression was used to analyze the influencing factors for prognosis of intravenous thrombolysis in ACI patients.The predictive value of CYP2C19 gene polymorphism and serum NT-proBNP level in predicting the prognosis of intrave-nous thrombolysis in ACI patients was analyzed by receiver operating characteristic curves.Results The age,hyperten-sion ratio,diabetes ratio,National Institutes of Health Stroke(NIHSS)score at admission and fasting blood glucose level in the poor prognosis group were higher than those in the good prognosis group(all P<0.05).There was a statistically sig-nificant difference in CYP2C19 gene polymorphism between the poor prognosis group and the good prognosis group(P<0.05),and the serum NT-proBNP level in the poor prognosis group was higher than that in the good prognosis group(P<0.05).The CYP2C19 gene polymorphism(rs=0.362)and serum NT-proBNP level(r=0.426)were positively correlated with mRS score in ACI patients(both P<0.05).High NIHSS score,CYP2C19 gene slow metabolism type,and high se-rum NT-proBNP levels were risk factors for poor prognosis in ACI patients(all P<0.05).The area under the curve of CYP2C19 gene polymorphism and serum NT-proBNP levels alone and in combination for the prognosis of intravenous thrombolysis in ACI patients was 0.752,0.786,and 0.861,respectively,and the area under the curve of the combina-tion of the two was higher than that of either alone(all P<0.05).Conclusion CYP2C19 gene polymorphism and high level of NT-proBNP are risk factors for poor prognosis in ACI patients undergoing intravenous thrombolysis,and the combi-nation of the two has higher predictive value for poor prognosis.

acute cerebral infarctionintravenous thrombolysisCYP2C19 gene polymorphismN-terminal B-type brain natriuretic peptide precursor

钱倩、张静、张欣、邢晓明、边伟林

展开 >

保定市第一中心医院神经内科,河北保定 071000

保定市人民医院放射科

急性脑梗死 静脉溶栓 CYP2C19基因多态性 N末端B型脑利钠肽前体

河北省卫生健康委科研基金项目

20220288

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(4)
  • 3